KUBTEC Marks 20 Years of Innovation in Medical Technology
This week marks a significant milestone for KUBTEC, as the company celebrates its 20th anniversary of delivering advanced X-ray cabinet systems that have transformed both clinical care and scientific research.
Founded in 2005, KUBTEC emerged with a vision to enhance X-ray imaging to improve cancer care. Over the span of two decades, the company has positioned itself as a global leader in specimen imaging, particularly in breast cancer surgery and pathology, subsequently powering discoveries in preclinical and life sciences research.
Vikram Butani, CEO and Co-Founder of KUBTEC, reflected on the journey, stating, "From the very beginning, we set out to make a difference in how imaging could inform better decisions - in the operating room, in the lab, and beyond. What began as a bold idea has expanded into a global entity with systems installed in over 40 countries. Whether in breast cancer surgery or advanced research, our focus has always been on delivering clarity through innovation."
KUBTEC's Medical division is noted for pioneering technologies such as 3D Specimen Tomosynthesis and the Image Blender™, which significantly enhance precision and workflow efficiency in breast surgery and pathology. Concurrently, its Scientific business continues to empower advancements in preclinical research through versatile X-ray imaging and irradiator systems.
Recently, KUBTEC has broadened its reach beyond its traditional core in both business segments. The acquisition of GammaPRO™, an intraoperative gamma localization technology, has strengthened KUBTEC Medical's role across the surgical continuum. Furthermore, KUBTEC Scientific ventured into the agriculture sector with the launch of XSEED™, a dedicated line of imaging systems to facilitate quicker and more efficient seed analysis. These strategic initiatives highlight the company’s ambition to drive growth and impact in its third decade.
KUBTEC's commitment to innovation and global outreach is evident in its receipt of five Marcum Tech Top 40 awards, recognizing rapid growth in Connecticut's technology sector. The company’s international expansion efforts also make it a contender for the Connecticut District Export Council award, acknowledging significant contributions to the state's manufacturing exports.
Reflecting on the company’s evolution, Preeti Butani, Co-Founder of KUBTEC, emphasized the importance of people in driving progress. "At KUBTEC, we've built more than a company—we've built a community of passionate individuals who are dedicated to making a difference," she stated. "Our culture revolves around integrity, curiosity, and shared purpose. Whether helping a surgeon avoid a second surgery or supporting researchers in uncovering new insights, our work is deeply rooted in social impact, which inspires us daily."
Looking ahead, KUBTEC plans to expand its technology portfolio through both innovation and acquisition, invest in intelligent software solutions, and strengthen partnerships that lead to improved patient outcomes and scientific breakthroughs. The company places a strong emphasis on sustainability, education, and equity in access to transformative technologies.
Vikram Butani further commented, "This anniversary is a celebration for everyone involved in our story—our customers, partners, and especially our employees. We are proud of our achievements and even more excited about the future."
Frequently Asked Questions
What is KUBTEC known for?
KUBTEC is known for its advanced X-ray imaging systems that enhance clinical care and drive scientific research, particularly in breast cancer surgery and pathology.
When was KUBTEC founded?
KUBTEC was founded in 2005 with a mission to revolutionize X-ray imaging technology.
What innovative technologies has KUBTEC developed?
KUBTEC has developed several innovative technologies, including 3D Specimen Tomosynthesis and the Image Blender™, which improve workflow efficiency and precision in surgery.
What recent expansions has KUBTEC made?
KUBTEC has expanded into agriculture with the launch of XSEED™, and acquired GammaPRO™ to enhance its surgical capabilities.
What are KUBTEC's future plans?
KUBTEC plans to further innovate its technology, invest in software solutions, and strengthen partnerships to improve patient outcomes and drive scientific breakthroughs.
